Award
NIH Reporter #5R01HL162120-04
Bioengineering a novel therapeutic protein complex to minimize the effects of medical device induced hemolysis
Recipient
National Heart Lung and Blood Institute (NHLBI), part of NIH
Award Amount
$631,536.00
Ceiling
$631,536.00
Awarded
February 19, 2025
Identifier
5R01HL162120-04
NIH grant awarded to develop a therapeutic protein complex to minimize hemolysis from medical devices, involving bioengineering and animal studies.
Description
This is a NIH grant project focused on developing a therapeutic protein complex to reduce hemolysis caused by blood pumps in medical devices, with a focus on cardiopulmonary bypass procedures. The project involves bioengineering, animal studies, and modeling to determine intervention timing and efficacy.